From cells to signaling cascades: Manipulation of innate immunity by Toxoplasma gondii

FEMS Immunology and Medical Microbiology

Volumn 39, Issue 3, 2003, Pages 193-203

  Denkers, Eric Y ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Cytokine; Immune evasion; Infection protozoan

Indexed keywords

ADAPTOR PROTEIN; ARACHIDONATE 5 LIPOXYGENASE; CASPASE; CHEMOKINE RECEPTOR CCR5; CYCLOPHILIN; DIFFERENTIATION ANTIGEN; DNA BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; GAMMA ACTIVATED FACTOR, 91 KD; GAMMA INTERFERON; GAMMA-ACTIVATED FACTOR, 91-KD; HEAT SHOCK PROTEIN 70; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; LIPOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MYELOID DIFFERENTIATION FACTOR 88; PARASITE ANTIGEN; PROSTAGLANDIN E2; STAT1 PROTEIN; STAT4 PROTEIN; TOLL LIKE RECEPTOR; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL; ANTIGEN PRESENTING CELL; APOPTOSIS; CELLULAR IMMUNITY; CORRELATION ANALYSIS; DENDRITIC CELL; DOWN REGULATION; DRUG MECHANISM; ENCEPHALITIS; GAMMA IRRADIATION; HELICOBACTER HEPATICUS; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGY; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; METABOLISM; NEUTROPHIL; NONHUMAN; PARASITE; PARASITOLOGY; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TOXOPLASMA; TOXOPLASMA GONDII; TOXOPLASMOSIS; ULTRAVIOLET IRRADIATION;

EID: 0345016346     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00279-7     Document Type: Short Survey

References (96)

1. Luft B.J., Remington J.S. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15:1992;211-222.
2. Remington, J.S., McLeod, R. and Desmonts, G. (1995) Toxoplasmosis. In: Infectious Diseases of the Fetus and Newborn Infant. (Remington, J.S. and Klein, J.O., Eds.), pp. 140-267. W.B. Saunders Co., Philadelphia, PA.
3. Duncanson P., Terry R.S., Smith J.E., Hide G. High levels of congenital transmission of Toxoplasma gondii in a commercial sheep flock. Int. J. Parasitol. 31:2001;1699-1703.
4. Hill D., Dubey J.P. Toxoplasma gondii: transmission, diagnosis and prevention. Clin. Microbiol. Infect. 8:2002;634-640.
5. Carruthers V.B. Host cell invasion by the opportunistic pathogen Toxoplasma gondii. Acta Trop. 81:2002;111-122.
6. Dubey J.P., Lindsay D.S., Speer C.A. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin. Microbiol. Rev. 11:1998;267-299.
7. Denkers E.Y., Gazzinelli R.T. Regulation and function of T cell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11:1998;569-588.
8. Lighvani A.A., Frucht D.M., Jankovic D., Yamane H., Aliberti J., Hissong B.D., Nguyen B.V., Gadina M., Sher A., Paul W.E., O'Shea J.J. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA. 98:2001;15137-15142.
9. Collazo C.M., Yap G.S., Hieny S., Caspar P., Feng C.G., Taylor G.A., Sher A. The function of gamma interferon-inducible GTP-binding protein IGTP in host resistance to Toxoplasma gondii is Stat1 dependent and requires expression in both hematopoietic and non-hematopoietic cellular compartments. Infect. Immun. 70:2002;6933-6939.
10. Gavrilescu, L.C., Del Rio, L., Butcher, B.A. and Denkers, E.Y. (2003) STAT1 is essential for anti-microbial effector function but dispensible for IFN-gamma production during Toxoplasma gondii infection. Submitted.
11. Cai G., Radzanowski T., Villegas E.N., Kastelein R., Hunter C.A. Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii. J. Immunol. 165:2000;2619-2627.
12. Yap G.S., Sher A. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology. 201:1999;240-247.
13. Alexander J., Hunter C.A. Immunoregulation during toxoplasmosis. Chem. Immunol. 70:1998;81-102.
14. Suzuki Y., Orellana M.A., Schreiber R.D., Remington J.S. Interferon-γ: The major mediator of resistance against Toxoplasma gondii. Science. 240:1988;516-518.
15. Scharton-Kersten T.M., Wynn T.A., Denkers E.Y., Bala S., Showe L., Grunvald E., Hieny S., Gazzinelli R.T., Sher A. In the absence of endogenous IFN-γ mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:1996;4045-4054.
16. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol. 149:1992;175-180.
17. Sher A., Oswald I.O., Hieny S., Gazzinelli R.T. Toxoplasma gondii induces a T-independent IFN-γ response in NK cells which requires both adherent accessory cells and TNF-α J. Immunol. 150:1993;3982-3989.
18. Hunter C.A., Subauste C.S., Van Cleave V.H., Remington J.S. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect. Immun. 62:1994;2818-2824.
19. Fukao T., Frucht D.M., Yap G., Gadina M., O'Shea J.J., Koyasu S. Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses. J. Immunol. 166:2001;4446-4455.
20. Gazzinelli R.T., Hieny S., Wynn T., Wolf S., Sher A. IL-12 is required for the T-cell independent induction of IFN-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA. 90:1993;6115-6119.
21. Reis e Sousa C., Hieny S., Scharton-Kersten T., Jankovic D., Charest H., Germain R.N., Sher A. In vivo microbial stimulation induces rapid CD40L-independent production of IL-12 by dendritic cells and their re-distribution to T cell areas. J. Exp. Med. 186:1997;1819-1829.
22. Bliss S.K., Zhang Y., Denkers E.Y. Murine neutrophil stimulation by Toxoplasma gondii antigen drives high level production of IFN-γ- independent IL-12. J. Immunol. 163:1999;2081-2088.
23. Szabo S.J., Sullivan B.M., Peng S.L., Glimcher L.H. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21:2003;713-758.
24. Cai G., Kastelein R., Hunter C.A. Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infect. Immun. 68:2000;6932-6938.
25. Takeda A., Hamano S., Yamanaka A., Hanada T., Ishibashi T., Mak T.W., Yoshimura A., Yoshida H. Cutting edge: Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170:2003;4886-4890.
26. Yap G., Pesin M., Sher A. IL-12 is required for the maintenance of IFN-γ production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol. 165:2000;628-631.
27. Scharton-Kersten T., Yap G., Magram J., Sher A. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185:1997;1-13.
28. Collazo C.M., Yap G.S., Sempowski G.D., Lusby K.C., Tessarollo L., Vande Woude G.F., Sher A., Taylor G.A. Inactivation of LRG-47 and IRG-47 reveals a family of interferon-γ-inducible genes with essential, pathogen-specific roles in resistance to infection. J. Exp. Med. 194:2001;181-187.
29. Yap G.S., Sher A. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-γ and tumor necrosis factor (TNF)-α-dependent host resistance to the intracellular pathogen, Toxoplasma gondii. J. Exp. Med. 189:1999;1083-1091.
30. Gazzinelli R.T., Wysocka M., Hayashi S., Denkers E.Y., Hieny S., Caspar P., Trinchieri G., Sher A. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:1994;2533-2543.
31. + T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α J. Immunol. 157:1996;798-805.
32. Neyer L.E., Grunig G., Fort M., Remington J.S., Rennick D., Hunter C.A. Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect. Immun. 65:1997;1675-1682.
33. + T cell-dependent, IFN-γ-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 184:1996;597-607.
34. Suzuki Y., Sher A., Yap G., Park D., Ellis Neyer L., Liesenfeld O., Fort M., Kang H., Gufwoli E. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J. Immunol. 164:2000;5375-5382.
35. Sibley L.D., Howe D.K. Genetic basis of pathogenicity in toxoplasmosis. Curr. Top. Microbiol. Immunol. 216:1996;4-15.
36. Gavrilescu L.C., Denkers E.Y. IFN-γ overproduction and high level apoptosis are associated with high but not low virulence Toxoplasma gondii infection. J. Immunol. 167:2001;902-909.
37. Mordue D.G., Monroy F., La Regina M., Dinarello C.A., Sibley L.D. Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J. Immunol. 167:2001;4574-4584.
38. Boothroyd J.C., Grigg M.E. Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease. Curr. Opin. Microbiol. 5:2002;438-442.
39. Butcher B.A., Denkers E.Y. Mechanism of entry determines ability of Toxoplasma gondii to inhibit macrophage proinflammatory cytokine production. Infect. Immun. 70:2002;5216-5224.
40. Schulz O., Edwards A.D., Schito M., Aliberti J., Manickasingham S., Sher A., Reis e Sousa C. CD40 triggering by dendritic cells in vivo requires a microbial priming signal. Immunity. 13:2000;453-462.
41. Seguin R., Kasper L.H. Sensitized lymphocytes and CD40 ligation augment interleukin-12 production by human dendritic cells in response to Toxoplasma gondii. J. Infect. Dis. 179:1999;467-474.
42. Reichmann G., Walker W., Villegas E.N., Craig L., Cai G., Alexander J., Hunter C.A. The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis. Infect. Immun. 68:2000;1312-1318.
43. Straw A.D., MacDonald A.S., Denkers E.Y., Pearce E.J. CD154 plays a central role in regulating dendritic cell activation during infections that induce Th1 or Th2 responses. J. Immunol. 170:2003;727-734.
44. Bourguin I., Moser M., Buzoni-Gatel D., Tielemens F., Bout D., Urbain J., Leo L. Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo. Infect. Immun. 66:1998;4867-4874.
45. Bliss S.K., Marshall A.J., Zhang Y., Denkers E.Y. Human polymorphonuclear leukocytes produce IL-12, TNF-α, and the chemokines macrophage-inflammatory protein-1α and -1β in response to Toxoplasma gondii antigens. J. Immunol. 162:1999;7369-7375.
46. Bliss S.K., Butcher B.A., Denkers E.Y. Rapid recruitment of neutrophils with prestored IL-12 during microbial infection. J. Immunol. 165:2000;4515-4521.
47. Gordon J.R., Galli S.J. Release of both preformed and newly synthesized tumor necrosis factor a (TNF-α)/cachectin by mouse mast cells stimulated via the FcεRI. A mechanism for the sustained activation of mast cell-derived TNF-α during IgE-dependent biological responses. J. Exp. Med. 174:1991;103-107.
48. Del Rio L., Bennouna S., Salinas J., Denkers E.Y. CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection. J. Immunol. 167:2001;6503-6509.
49. Bennouna, S., Bliss, S.K., Curiel, T.J. and Denkers, E.Y. (2003) Cross talk in the innate immune system: neutrophils instruct early recruitment and activation of dendritic cells during microbial infection. J. Immunol. In press.
50. Denkers E.Y., Del Rio L.D., Bennouna S. Production of IL-12 and other cytokines during microbial infection. Chem. Immunol. 83:2003;95-114.
51. Bliss S.K., Gavrilescu L.C., Alcaraz A., Denkers E.Y. Neutrophil depletion during Toxoplasma gondii infection leads to impaired immunity and lethal systemic pathology. Infect. Immun. 69:2001;4898-4905.
52. Romani L., Bistoni F., Puccetti P. Initiation of T-helper cell immunity to Candida albicans by IL-12: the role of neutrophils. Chem. Immunol. 68:1997;110-135.
53. Tateda K., Moore T.A., Deng J.C., Newstead M.W., Zeng X., Matsukawa A., Swanson M.S., Yamaguchi K., Standiford T.J. Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia. J. Immunol. 166:2001;3355-3361.
54. Nakano H., Yanagita M., Gunn M.D. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194:2001;1171-1178.
55. Dalod M., Salazar-Mather T.P., Malmgaard L., Lewis C., Asselin-Paturel C., Briere F., Trinchieri G., Biron C.A. Interferon α/β and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195:2002;517-528.
56. Scharton-Kersten T., Contursi C., Masumi A., Sher A., Ozato K. ICSBP-deficient mice display impaired resistance to intracellular infection due to a primary defect in IL-12 p40 induction. J. Exp. Med. 186:1997;1523-1534.
57. Masumi A., Tamaoki S., Ming Wang I., Ozato K., Komuro K. IRF-8/ICSBP and IRF-1 cooperatively stimulate mouse IL-12 promoter activity in macrophages. FEBS Lett. 531:2002;348-353.
58. Murphy T., Cleveland M., Kulezka P., Magram J., Murphy K. Regulation of interleukin 12 p40 expression through an NF-κB half-site. Mol. Cell. Biol. 15:1995;5258-5267.
59. Plevy S.E., Gemberling J.H.M., Hsu S., Dorner A.J., Smale S.T. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol. Cell. Biol. 17:1997;4572-4588.
60. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 21:2003;335-376.
61. Scanga C.A., Aliberti J., Jankovic D., Tilloy F., Bennouna S., Denkers E.Y., Medzhitov R., Sher A. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168:2002;5997-6001.
62. Tomavo S., Schwartz R.T., Dubremetz J.-F. Evidence for glycosyl-phosphatidylinositol anchoring of Toxoplasma gondii major surface proteins. Mol. Cell. Biol. 9:1989;4576-4580.
63. Debierre-Grockiego, F., Azzouz, N., Schmidt, J., Dubremetz, J.-F., Geyer, H., Geyer, R., Weingardt, R., Schmidt, R.R. and Schwartz, R.T. (2003) Roles of glycosylphosphatidylinositols of Toxoplasma gondii. Induction of TNFα production in macrophages. J. Biol. Chem., in press.
64. Camargo M.M., Almeida I.C., Pereira M.E.S., Ferguson M.A.J., Travassos L.R., Gazzinelli R.T. Glycosylphosphotidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J. Immunol. 158:1997;5890-5901.
65. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:2000;621-663.
66. Sanjabi S., Hoffmann A., Liou H.C., Baltimore D., Smale S.T. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl. Acad. Sci. USA. 97:2000;12705-12710.
67. Mason N., Aliberti J., Caamano J.C., Liou H.C., Hunter C.A. Identification of c-Rel-dependent and -independent pathways of Il-12 production during infectious and inflammatory stimuli. J. Immunol. 168:2002;2590-2594.
68. Caamano J., Hunter C.A. NF-κB family of transcription factors: central regulators of innate and adaptive immune functions. Clin. Microbiol. Rev. 15:2002;414-429.
69. Aliberti J., Valenzuela J.G., Carruthers V.B., Hieny S., Andersen J., Charest H., Reis e Sousa C., Fairlamb A., Ribeiro J.M., Sher A. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat. Immunol. 4:2003;485-490.
70. Aliberti J., Reis e Sousa C., Schito M., Hieny S., Wells T., Huffnage G.B., Sher A. CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells. Nat. Immunol. 1:2000;83-87.
71. Braun M.C., Kelsall B.L. Regulation of interleukin-12 production by G-protein-coupled receptors. Microb. Infect. 3:2001;99-107.
72. Gazzinelli R.T., Denkers E.Y., Sher A. Host resistance to Toxoplasma gondii: Model for studying the selective induction of cell-mediated immunity by intracellular parasites. Infect. Agents Dis. 2:1993;139-149.
73. Reiner S.L., Zheng S., Wang Z.-E., Stowring L., Locksley R.M. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J. Exp. Med. 179:1994;447-456.
74. Carrera L., Gazzinelli R.T., Badolato R., Hieny S., Muller W., Kuhn R., Sacks D.L. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183:1996;515-526.
75. Belloni A., Aubert D., Gomez Martin J.E., Le Naour R., Bonhomme A., Guenounou M., Pinon J.M. Involvement of tumor necrosis factor-α during infection of human monocytic cells by Toxoplasma gondii. Parasitol. Res. 86:2000;406-412.
76. Denkers E.Y., Kim L., Butcher B.A. In the belly of the beast: subversion of macrophage proinflammatory signaling cascades during Toxoplasma gondii infection. Cell. Microbiol. 5:2003;75-83.
77. Luder C.G.K., Lang T., Beurle B., Gross U. Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii. Clin. Exp. Immunol. 112:1998;308-316.
78. Luder C.G.K., Lang C., Giraldo-Velasquez M., Algner M., Gerdes J., Gross U. Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA. J. Neuroimmunol. 134:2003;12-24.
79. Luder C.G.K., Walter W., Beuerle B., Maeurer M.J., Gross U. Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1a. Eur. J. Immunol. 31:2001;1475-1484.
80. Tato C.M., Hunter C.A. Host-pathogen interactions: subversion and utilization of the NF-κB pathway during infection. Infect. Immun. 70:2002;3311-3317.
81. Butcher B.A., Kim L., Johnson P.F., Denkers E.Y. Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NFκB. J. Immunol. 167:2001;2193-2201.
82. Shapira S.S., Speirs K., Gerstein A., Caamano J., Hunter C.A. Suppression of NF-κB activation by infection with Toxoplasma gondii. J. Infect. Dis. 185:2002;S66-S72.
83. Dobbin C.A., smith N.C., Johnson A.M. Heat shock protein 70 is a potential virulence factor in murine Toxoplasma gondii infection via immunomodulation of host NF-κB and nitric oxide. J. Immunol. 169:2002;958-965.
84. Feinstein D.L., Galea E., Reis D.J. Suppression of glial nitric oxide synthase induction by heat shock: effects on proteolytic degradation of IkappaB-alpha. Nitric Oxide. 1:1997;167-176.
85. Nash P.B., Purner M.B., Leon R.P., Clarke P., Duke R.C., Curiel T.J. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J. Immunol. 160:1998;1824-1830.
86. Goebel S., Gross U., Luder C.G.K. Inhibition of host cell apoptosis by Toxoplasma gondii is accompanied by reduced activation of the caspase cascade and alterations of poly(ADP-ribose) polymerase expression. J. Cell Sci. 114:2001;3495-3505.
87. Goebel S.G., Gross U., Luder C.G.K. Inhibition of host cell apoptosis by Toxoplasma gondii is accompanied by reduced activation of the caspase cascade and alterations of poly(ADP-ribose) polymerase activation. J. Cell Sci. 114:2001;3495-3505.
88. Reis e Sousa C., Yap G., Schultz O., Rogers N., Schito M., Aliberti J., Hieny S., Sher A. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-based immunopathology. Immunity. 11:1999;637-647.
89. Aliberti J., Reis e Sousa C., Serhan C.N., Sher A. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat. Immunol. 3:2002;76-82.
90. 4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J. Exp. Med. 196:2002;1253-1262.
91. Aliberti J., Sher A. Positive and negative regulation of pathogen induced dendritic cell function by G-protein coupled receptors. Mol. Immunol. 38:2001;891-893.
92. Hunter C.A., Ellis-Neyes L.A., Slifer T., Kanaly S., Grunig G., Fort M., Rennick D., Araujo F.G. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158:1997;3311-3316.
93. Kullberg M.C., Ward J.M., Gorelick P.L., Caspar P., Hieny S., Cheever A., Jankovic D., Sher A. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12 and gamma interferon-dependent mechanism. Infect. Immun. 66:1998;5157-5166.
94. Kullberg M.C., Jankovic D., Gorelick P.L., Caspar P., Letterio J.J., Cheever A.W., Sher A. Bacteria-triggered CD4+ T regulatory cells suppress Helicobacter hepaticus-induced colitis. J. Exp. Med. 196:2002;505-515.
95. Lecordier L., Mercier C., Sibley L.D., Cesbron-Delauw M.-F. Transmembrane insertion of the Toxoplasma gondii GRA5 protein occurs after soluble secretion into the host cell. Mol. Biol. Cell. 10:1999;1277-1287.
96. Beckers C.J.M., Dubremetz J.-F., Mercereau-Puijalon O., Joiner K.A. The Toxoplasma gondii rhoptry protein ROP 2 is inserted into the parasitophorous vacuole membrane, surrounding the intracellular parasite, and is exposed to the host cell cytoplasm. J. Cell Biol. 127:1994;947-961.